United States· US:65862-293_d170e87b-de05-4fc4-8e53-9367615e77f1
Rosuvastatin Calcium
A rosuvastatin product containing rosuvastatin calcium, registered in United States by Aurobindo Pharma Limited. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin is registered in 18 of 19 countries.
Countries holding a registration under ATC C10AA07 (rosuvastatin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Rosuvastatin · ATC C10AA07
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rosuvastatin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.036 in United States to $0.73 in Switzerland — a ×20 gap.
- United States: $0.036 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Rosuvastatin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.73
- ES Spain$0.39
- IT Italy$0.26
- FR France$0.17
- US United States$0.036 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ROSUVASTATIN CALCIUM
- Manufacturer
- Aurobindo Pharma Limited
- Country
- United States (US)
- ATC code
- C10AA07
- ATC class
- Rosuvastatin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 26, 2026
Packs & prices · 10
- ndc1165862-293-05
- ndc1165862-293-06
- ndc1165862-293-30
- ndc1165862-293-90
- ndc1165862-293-99
- ndc116586229305500 TABLET, FILM COATED in 1 BOTTLE (65862-293-05)
- ndc11658622930610 BLISTER PACK in 1 CARTON (65862-293-06) / 6 TABLET, FILM COATED in 1 BLISTER PACK
- ndc11658622933030 TABLET, FILM COATED in 1 BOTTLE (65862-293-30)
- ndc11658622939090 TABLET, FILM COATED in 1 BOTTLE (65862-293-90)
- ndc1165862293991000 TABLET, FILM COATED in 1 BOTTLE (65862-293-99)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
689 interactions on record for rosuvastatin.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rosuvastatin · interactions on record
689 records
- 29 severe
- 200 moderate
- 20 minor
- 403 info
Most severe, free to view
- ClofibrateC10AB01severe
- GemfibrozilC10AB04severe
- FenofibrateC10AB05severe
- MipomersenC10AX11severe
37 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C10AA07
Rosuvastatin, as other registers publish it.
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6695b16-385e-42ac-a179-db77c7c9de6f GET /v1/drugs/e6695b16-385e-42ac-a179-db77c7c9de6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "ROSUVASTATIN CALCIUM",
"productndc": "65862-293",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA079170",
"marketing_category": "ANDA"
}See everything about rosuvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.